Novel Mutations Mapping to the Fourth Sodium Channel Domain of Nav1.7 Result in Variable Clinical Manifestations of Primary Erythromelalgia. This evidence concerns the gene SCN9A and sodium channelopathy-related small fiber neuropathy.